DGAP-News: Announcement: 4SC to host conference call on 7 November 2013 to present Q3 2013 results
(firmenpresse) - DGAP-News: 4SC AG / Key word(s): Miscellaneous
Announcement: 4SC to host conference call on 7 November 2013 to
present Q3 2013 results
31.10.2013 / 15:00
---------------------------------------------------------------------
Announcement
4SC to host conference call on 7 November 2013 to present Q3 2013 results
Planegg-Martinsried, Germany, 31 October 2013 - 4SC AG (Frankfurt, Prime
Standard: VSC), a discovery and development company of targeted small
molecule drugs for cancer and autoimmune diseases, will announce third
quarter results 2013 of the 4SC Group and publish the company's 9 months
financial report 2013 on 7 November 2013. On this day the Management Board
of 4SC AG will host a conference call at 3pm CET (9am EST) to inform about
the consolidated financial statements and important developments in the
reporting period and beyond.
Investors, financial analysts, and journalists participating in the
conference call can access via the following telephone numbers:
Date: 7 November 2013
Time: 3pm CET (9am EST)
Dial-in:
+49-6103-485-3001 (Germany)
+44-207-153-2027 (UK)
+1-480-629-9822 (USA)
+49-6103-485-3001 (other countries)
Conference-ID: 4647613
After the conference call a replay will be available in the section
'Investors' / 'Events&Presentations' / 'Conference Calls&Webcasts' of
the website www.4sc.com.
Ends
About 4SC
The Group managed by 4SC AG (ISIN DE0005753818) discovers and develops
targeted, small-molecule drugs for treating diseases with high unmet
medical needs in various cancer and autoimmune indications. These drugs are
intended to provide innovative treatment options that are more tolerable
and efficacious than existing therapies, and provide a better quality of
life. The Company's pipeline comprises promising products that are in
various stages of clinical development. 4SC's aim is to generate future
growth and enhance its enterprise value by entering into partnerships with
leading pharmaceutical and biotech companies. Founded in 1997, 4SC had a
headcount of 78 employees (57 FTEs) at 30 September 2013. 4SC AG has been
listed on the Prime Standard of the Frankfurt Stock Exchange since December
2005.
Cautionary statement regarding forward-looking statements
This press release contains certain forward-looking statements. Any
forward-looking statement applies only on the date of this press release.
By their nature, forward-looking statements are subject to a number of
known and unknown risks and uncertainties that may or may not occur in the
future and as a result of which the actual results and performance may
differ substantially from the expected future results or performance
expressed or implied in the forward looking statements. No warranties or
representations are made as to the accuracy, achievement or reasonableness
of such statements, estimates or projections, and 4SC AG has no obligation
to update any such information or to correct any inaccuracies herein or
omission herefrom which may become apparent.
For more information please visit www.4sc.com or contact:
4SC AG
Jochen Orlowski, Corporate Communications&Investor Relations
jochen.orlowski(at)4sc.com, Tel.: +49-89-7007-6366
MC Services
Raimund Gabriel
raimund.gabriel(at)mc-services.eu , Tel.: +49-89-2102-2830
The Trout Group
Chad Rubin
crubin(at)troutgroup.com, Tel.: +1-646-378-2947
End of Corporate News
---------------------------------------------------------------------
31.10.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: 4SC AG
Am Klopferspitz 19a
82152 Martinsried
Germany
Phone: +49 (0)89 7007 63-0
Fax: +49 (0)89 7007 63-29
E-mail: public(at)4sc.com
Internet: www.4sc.de
ISIN: DE0005753818
WKN: 575381
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, München, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
237255 31.10.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 31.10.2013 - 15:00 Uhr
Sprache: Deutsch
News-ID 311441
Anzahl Zeichen: 6053
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 382 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Announcement: 4SC to host conference call on 7 November 2013 to present Q3 2013 results"
steht unter der journalistisch-redaktionellen Verantwortung von
4SC AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
